thyssenkrupp nucera (NCH2) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
25 Feb, 2026Opening remarks and agenda
Welcomed shareholders, introduced new board members, and acknowledged outgoing members for their contributions.
Outlined the meeting format, emphasizing transparency, shareholder rights, and technical participation details.
Confirmed all proposals and motions were published and distributed in accordance with regulations.
Board and executive committee updates
Noted changes in the Supervisory Board, including new appointments and farewells to departing members.
Highlighted the addition of members with expertise in international management, IT, innovation, and sustainability.
Financial performance review
Reported over EUR 845 million in revenue for fiscal year 2024/2025, with positive EBIT and improved free cash flow.
Equity ratio reached 65%, with available liquidity of EUR 680 million, reflecting strong financial stability.
Share price stabilized after market fluctuations, and cost optimization measures were implemented.
Latest events from thyssenkrupp nucera
- Order intake guidance raised to €550–850m, but sales and EBIT guidance lowered for FY 2025/26.NCH2
Status update18 Mar 2026 - Record chlor-alkali sales and improved margins offset green hydrogen softness; outlook cautious.NCH2
Q4 202513 Feb 2026 - Sales and EBIT declined sharply, but full-year guidance and order momentum remain strong.NCH2
Q1 202611 Feb 2026 - Record sales and robust backlog, but AWE outlook clouded by regulatory and market delays.NCH2
Q3 20241 Feb 2026 - Record sales and resilient AWE and CA growth drive strong performance amid market challenges.NCH2
Q4 202411 Jan 2026 - Record Q1 sales and EBIT growth, with strong outlook and robust order backlog.NCH2
Q1 202523 Dec 2025 - Q3 sales fell, but raised guidance and margin gains highlight improved outlook.NCH2
Q3 202523 Nov 2025 - Sales and EBIT rose 31% YoY, with strong project execution and guidance confirmed.NCH2
Q2 202519 Nov 2025 - Record sales and expanding project pipeline highlight strong growth and market leadership.NCH2
Investor Presentation17 Jun 2025